As a feed additive, ascorbic acid has been shown to have a protective effect against bacterial and viral diseases and to reduce the impact of detrimental stress in chickens. This study examined the effect of ascorbic acid treatment on in vitro heterophil function by examining random migration and phagocytosisa nd bacterialk illing of Staphylococcuasu reus. Heterophils were evaluated in broiler chickens ranging from 5 to 16 wk of age, and age differences were seen. Significant increases in bacterial killing were found in heterophils treated with ascorbic acid, and this difference tended to be greater in chickens from 5 to 10.5 wk of age. No significant differences were found in phagocytosis or random migration, but ascorbic acid tended to decrease random migration. The most significant effect on in vitro heterophil function was an increase in bacterial killing. Received 11 December 1998 SUMMARY. As a feed additive, ascorbic acid has been shown to have a protective effect against bacterial and viral diseases and to reduce the impact of detrimental stress in chickens. This study examined the effect of ascorbic acid treatment on in vitro heterophil function by examining random migration and phagocytosis and bacterial killing of Staphylococcus aureus. Heterophils were evaluated in broiler chickens ranging from 5 to 16 wk of age, and age differences were seen. Significant increases in bacterial killing were found in heterophils treated with ascorbic acid, and this difference tended to be greater in chickens from 5 to 10.5 wk of age. No significant differences were found in phagocytosis or random migration, but ascorbic acid tended to decrease random migration. The most significant effect on in vitro heterophil function was an increase in bacterial killing.
Staphylococcal tenosynovitis and osteomyelitis are worldwide problems of broiler and broiler-breeder chickens and turkeys that result in increased condemnations at slaughter and decreased weight gain and egg production due to bacteremia and decreased mobility (20). This disease has resulted in economic losses in the poultry industry, and previous surveys have identified that staphylococcal tenosynovitis/arthritis and osteomyelitis account for a major proportion of musculoskeletal disease in poultry (28). The disease pathogenesis is poorly defined, but decreased leukocyte function, especially heterophils, may contribute to the chronic debilitating nature of the disease (5). This syndrome responds poorly to antibiotics and, so far, immunization has not been effective.
Critically important to both the human and veterinary medical communities is that staphylococcal bacteria are becoming resistant to antibiotics, e.g., the emergence of methicillin-and vancomycin-resistant strains of staphylococci. The use of ascorbic acid to improve cell function and protect against disease has been advocated in staphylococcal infections of humans (18,30) and various diseases of poultry (13, 19) . In humans, as chronic staphylococcal infections progress, plasma ascorbic acid concentrations decrease (18) . We previously demonstrated that ascorbic acid concentrations decreased during experimental staphylococcal infections in poultry. In humans, ascorbic acid has been documented to upregulate neutrophil chemotaxis, phagocytosis, and bacterial killing as well as to result in clinical improvement in staphylococcal infections (18) . As a means of therapy, ascorbic acid offers the important advantages of being nontoxic and economical and not conferring antibiotic resistance.
There is a need to determine if heterophil function, including phagocytosis and bacterial killing, can be increased by ascorbic acid treatment because this might contribute to the decreased mortality reported in the poultry literature. This study investigates the in vitro effects of ascorbic acid on heterophil random migration and phagocytosis and bacterial killing of S.
aureus.

MATERIALS AND METHODS
Preliminary data. An in vivo pilot study was conducted to determine plasma ascorbic acid concentrations in 6-to-8-wk-old broiler chickens with experimental staphylococcal arthritis (1 x 106 S. aureus 921-1 intravenous inoculation) (4) without ascorbic acid feed supplementation (n = 4) and with ascorbic acid feed supplementation (n = 3). Controls consisted of healthy chickens fed diets without (n = 3) and with ascorbic acid supplementation (n = 4). The in vivo study compared chickens being fed a regular ration (Start and Growth; Purina Mills, Inc., St. Louis, MO) and a 1000 ppm ascorbic acid-supplemented (Hoffman-Roche, Inc., Nutley, NJ) ration with and without experimental staphylococcal infections. Plasma for ascorbic acid analysis was collected into ethylenediaminetetraacetic acid (EDTA) vacutainer tubes, placed on ice, and immediately centrifuged at 4 C; the plasma was collected and stored at -70 C until analyzed. Plasma ascorbic acid analysis was performed by reverse phase high-performance liquid chromatography with electrochemical detection at Michigan State University, College of Veterinary Medicine, Nutritional Laboratory, East Lansing, MI, and results were reported in micromoles per liter.
Experimental design. Heterophils were collected from clinically healthy nonvaccinated Arbor Acres x Ross broiler chickens with complete blood counts within normal reference intervals. Chickens were housed in the Iowa State University Laboratory Animal Resource Facility with 16 hr light and 8 hr dark cycles and provided growth ration and water ad libitum. Heterophils were harvested from chickens at -10.5 wk and >11.0 wk of age, and assays were repeated over a 12 wk time period. Paired samples were used in each assay, and repetitions for each assay type are indicated below. Heterophils were incubated with either ascorbic acid (1 x 10-1 M) or Hanks' buffered salt solution (HBSS) without calcium or magnesium with 0.1% fetal bovine serum (FBS). Assays for random migration, phagocytosis, and bacterial killing were conducted at 41 C.
Heterophil separation and incubation. Heterophils were collected from 5-to-16-wk-old chickens and separated by a slight modification of a previously described technique (3,7). Solutions and reagents used in the heterophil separation were prewarmed in an incubator at 41 C for 20 min. A volume of 6 ml of whole blood was collected into 12-ml syringes with a 1:9 ratio of 10% EDTA (ED 2SS; Sigma Chemical Co., St. Louis, MO) to blood. The blood was gently mixed with 4 ml of 1% methylcellulose (25 cps, M-6385; Sigma) in 15-ml polypropylene tubes, and then the sample was divided into two tubes with 5 ml each and centrifuged at 25 g. After centrifugation, the plasma, with the buffy coat layer above the erythrocytes, was removed into separate tubes, and the erythrocyte interface was gently washed with HBSS without calcium or magnesium (14175-020, Gibco-BRL, Grand Island, NY), with 0.1% fetal bovine serum (FBS) (Intergen Co., Purchase, NY), to harvest the remaining heterophils. The tubes were filled with HBSS with 0.1% FBS, mixed, and centrifuged at 375 x g for 10 min. After centrifugation, the supernatant was discarded and the cell pellets were resuspended in HBSS with 0.1% FBS to 3 ml and placed on Ficoll-Hypaque gradients (Sigma) (specific gravity 1.077, 3 ml; over specific gravity 1.119, 3 ml). After centrifugation for 25 min at 260 X g, the 1.077/ 1.119 interface and 1.119 band were retained, and the top layer, including the white band of mononuclear cells, was discarded. The tubes were filled with HBSS with 0.1% FBS, inverted, and centrifuged at 375 x g for 10 min. The cell pellets were resuspen-ded to 3 ml in 1 50-ml polypropylene tube, then 25 ml of 0.87% NH4Cl in 0.1% KHCO3 was added, and the tubes were rocked for 7 min to lyse the remaining erythrocytes. After the 7 min, HBSS with 0.1% FBS was added for a total volume of 50 ml, mixed, and centrifuged for 15 min at 400 x g. The supernatant was discarded, and the cell pellet was resuspended to 2 ml and then divided into two 15-ml polypropylene tubes, filled with HBSS with 0.1% FBS, and centrifuged for 10 min at 375 x g. In the control tube, the heterophils were initially suspended to 1 ml in HBSS with 0.1% FBS and counted with an eosinophil unopette (Becton-Dickinson, Rutherford, NJ) and hemacytometer. Differential leukocyte counts were performed on cytospin preparations to exclude eosinophils from the final heterophil count, and then cells were suspended to an initial concentration of 3 x 106 heterophils/ml. The heterophils in the ascorbic acid sample were suspended at the same cell concentration with 1 x 10-1 M sodium ascorbate (A4034 L-ascorbic acid sodium; Sigma) in HBSS on the basis of previously published ascorbic acid concentrations (2) and incubated for 30 min at 21 C (2,31). After incubation, the cells were rinsed with HBSS with 0.1% FBS, centrifuged at 375 x g, and used for assays. The final heterophil concentration was adjusted for each assay. Heterophil purity (>95%) was examined by cytospin preparations and viability determined by trypan blue dye exclusion (>95%). In preliminary assays, the concentration of ascorbic acid was doubled, but no significant effect was noted (data not shown).
Bacteria and pooled sera. A characterized S. aureus strain 921-1, isolated from affected joints in a case of tenosynovitis, was used for heterophil/bacterial assays (6). Bacteria were kept frozen at -70 C and grown on blood agar plates; single colonies were harvested and grown in tryptic soy broth (TSB) overnight for 14 hr prior to each assay. For the bacterial killing assay, bacteria were washed three times for 15 min at 1290 x g at 4 C, opsonized for 20 min, and suspended to 5 x 107 colony-forming units/ml in HBSS, standardized by spectrophotometry, and verified by colony counts. The 125I labeling of S. aureus for phagocytic assays was performed as previously described (24) with slight modifications. Two milliliters of an overnight culture was inoculated into 500 ml of brain-heart infusion broth containing 500 RCi 1251 (Amersham, Arlington Heights, IL) and 10-5 M fluorodeoxyuridine (125FUdR) (F0305; Sigma) and incubated for 24 hr at 37 C. After incubation, the bacteria were divided into 10 50-ml vials and centrifuged at 1000 x g for 20 min; the supernatant was removed and heat-killed for 1 hr at 56 C. Bacteria were then washed with phosphate-buffered salt solution (PBSS) 10 min at 450 x g, the supernatant was removed, bacterial counts were standardized by spectrophotometry, and 125S-iododeoxyuridine-labeled bacteria were stored at -70 C until used.
Opsonization was done with pooled nonimmune avian sera collected from broiler chickens raised in Oregon and Iowa, filtered, and stored at -70 C. Serum titers against S. aureus were determined by microtiter plate agglutination, as previously described (3), to be 1:32.
Random migration. Random migration under agarose (n = 13 paired samples) was used to measure the ability of heterophils to move randomly (1,24). Agar plates were prepared with buffered sodium bicarbonate (NaHCO3, 0.026 M, pH 7.2) added to 10 x M199 medium with Hanks' salts and L-glutamine (11181-039; Gibco-BRL) containing 10% pooled normal chicken serum, 0.8% agarose (Indubiose A37 HAA; IBF Biotechnics Inc., Columbia, MD), and 1% penicillin-streptomycin solution (P0781; Sigma) (1). Five-milliliter amounts of the agarose medium were dispensed into 60 x 15-mm tissue culture petri plates (Becton-Dickinson Labware, Lincoln Park, NJ), allowed to solidify, and stored in an airtight container at 4 C with humidity. Heterophils were diluted to 5 x 107 heterophils/ml and 10 pA was placed in prepunched 2.0-mm agar wells with samples run in duplicate. Plates were placed in a humidified incubator with 5% CO2 at 41 C and incubated for 18 hr. After incubation, the plates were fixed with 8% glutaraldehyde for 60 min, the agar was removed, and adherent heterophils were stained with 0.1% crystal violet for 10 min, dried, and examined. The area of migration was determined by measuring the radius with a microscope ocular grid. The circular migration pattern (in millimeters2) was calculated by the formula A = rrR2 and subtracting the area of the well from the total area.
Phagocytosis. The percentage of phagocytosis of S. aureus (n = 16 paired samples) was determined by measuring the ability of heterophils to ingest opsonized 1251-iododeoxyuridine-labeled S. aureus (24) . In preliminary studies, pooled normal chicken serum was compared with a previously characterized staphylococcal antisera (3) as an opsonin, and no significant differences were found in the phagocytic assay 
Heterophil separation.
Initially, not enough heterophils were collected on the same day to run all assays from individual chickens, but a majority of chickens had all three assays performed. The collection of peripheral blood was increased to 12 to 24 ml to run multiple assays with no adverse effect on adult broilers. The heterophil separation procedure was followed with the addition of more tubes for the methylcellulose and gradient steps because it was important to maintain the stated blood to reagent ratios. The yield of heterophils from 6 ml of blood ranged from 4 x 106/pl to 8.5 x 106/il, and from 12 ml of blood, the range was 8 x 106/pl to 18 X 106/pl. The critical factors for maximum heterophil yield were accurate centrifugation speeds and avoidance of any microclots in the blood samples. Random migration. Over all age groups, no significant differences (P -0.05) were found in random migration between heterophils treated with ascorbic acid or HBSS, but comparisons of individual chickens (n = 4) did have significant differences (P -0.05). When age groups were examined, no significant differences (P -0.05) were noted. In all age groups, ascorbic acid tended to decrease random migration of heterophils (mean ? SD, 22.9 ? 12.7 mm2) compared with heterophils treated with HBSS (26.1 ? 15.6 mm2) . Ten of 13 chickens assayed had decreased random migration when the heterophils were incubated with ascorbic acid.
Phagocytosis. For phagocytosis, no significant differences (P-0.05) were found between heterophils treated with ascorbic acid or HBSS for any age group. The means ? SD phagocytosis were 21.4 ? 7.7% for heterophils treated with HBSS and 20.4 ? 5.7% for heterophils incubated with ascorbic acid across all age groups.
Bacterial killing. In the MTT assay, a significant (P -0.05) increase in heterophil killing of S. aureus was seen when heterophils were incubated with ascorbic acid at 1 x 10-1 M and compared with bacterial killing when incubated in HBSS. There was a trend (significant at P -0.06) for heterophils from chickens -10.5 wk of age to have greater increases in bacterial killing vs. chickens -11.0 wk of age. When heterophils were incubated with ascorbic acid, the mean percentage of decrease in OD for chickens ?10.5 wk of age was 27.6% vs. 18.2% for chickens ?11.0 wk of age. When ascorbic acid-incubated heterophils were compared with HBSS incubation, individual bird heterophils varied from 16% to 44% in the decrease of OD that corresponded to an increase in bacterial killing. For all age groups, bacterial killing was 64 ? 12% for heterophils treated with HBSS and 71 ? 12% for heterophils treated with ascorbic acid. No direct bacterial killing was observed when ascorbic acid was incubated with bacteria, but there was a slight trend for bacterial numbers to increase when compared with incubation in HBSS.
DISCUSSION
The use of ascorbic acid to improve cell function and protect against disease has been advocated in both human medicine (18,23) and veterinary medicine, including poultry medicine (13,19) . In poultry, decreased ascorbic acid concentrations have been associated with stress (16), and administration of ascorbic acid has been associated with a protective effect against stress, e.g., corticosterone release (13,27). In poultry, ascorbic acid added to feed or water has been shown to ameliorate the effects of Escherichia coli and infectious bronchitis virus (9,13,14) . Recently, ascorbic acid was found to decrease mortality in broiler ascites and had no effect on performance parameters (17) .
A trend for ascorbic acid to decrease random migration of heterophils was found in our study. The effect of ascorbic acid may aid in keeping the inflammatory cells at the site of infection. In cattle, ascorbic acid decreased random migration (25). Additionally, studies in cattle demonstrated that the subcutaneous injection of ascorbic acid reversed the effects of dexamethasone alteration of neutrophil migration, oxidative metabolism, and antibody-dependent cytotoxicity (25). We did not see differences in the percentage of phagocytosis in heterophils treated with ascorbic acid and those treated with HBSS. The percentage of phagocytosis was similar, but slightly decreased, compared with previous reports of staphylococcal ingestion by avian heterophils (3,4,7). These differences could be due to the assay type because prior assays used flow cytometric evaluation of phagocytosis (3,7). In cattle, ascorbic acid tended to enhance S. aureus ingestion by bovine neutrophils (25). Followup studies were not performed to examine the use of ascorbic acid in disease prevention or as an additive to cattle feed. What effect the rumen microflora might have on ascorbic acid metabolism is unknown.
Of the assays used, significant differences were seen in cell-associated bacterial killing with the MTT assay. Even though the cells are washed in the MTT assay, complete removal of external bacteria cannot be guaranteed, and hence the assay is categorized as cell-associated bacterial killing. Because subsequent bacterial amplification is performed, the changes in OD readings are probably a more accurate reflection of heterophil-associated bacterial killing than comparisons of percentage of bacterial killing. Because ascorbic acid apparently will increase in vitro staphylococcal killing, the mechanism of ascorbic acid may be directly intracellular, extracellular, or both. The importance of ascorbic acid function as an extracellular antioxidant protecting the granulocyte, and possibly prolonging its functional life span, may be more critical for neutrophils that contain myeloperoxidase than for heterophils that primarily kill organisms via oxygen-independent pathways (11).
We found decreased plasma ascorbic acid concentrations in chickens with staphylococcal arthritis/tenosynovitis (Fig. 1 
